WO1996036737A1 - Sequençage de polynucleotides parallele et en multiplex - Google Patents

Sequençage de polynucleotides parallele et en multiplex Download PDF

Info

Publication number
WO1996036737A1
WO1996036737A1 PCT/US1996/007202 US9607202W WO9636737A1 WO 1996036737 A1 WO1996036737 A1 WO 1996036737A1 US 9607202 W US9607202 W US 9607202W WO 9636737 A1 WO9636737 A1 WO 9636737A1
Authority
WO
WIPO (PCT)
Prior art keywords
sample
detection
distinct
polynucleotide
separatory
Prior art date
Application number
PCT/US1996/007202
Other languages
English (en)
Inventor
Ely Michael Rabani
Original Assignee
Ely Michael Rabani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ely Michael Rabani filed Critical Ely Michael Rabani
Priority to AU57976/96A priority Critical patent/AU5797696A/en
Publication of WO1996036737A1 publication Critical patent/WO1996036737A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation

Definitions

  • the invention relates to the field of molecular biology .
  • each such differently terminated sample aliquot comprises a so-called "nested set" of populations of molecules of different length, up to the length of the input sample molecules, but identically having the specified 3' terminal base composition.
  • the length of each subpopulation within each such sample aliquot corresponds to a position of the base moiety, for which that sample aliquot has been treated, within the sample sequence.
  • the nested sets produced by both of these methods are conventionally separated according to length by electrophoresis through gel matrices, generally of polyacrylamide composition.
  • the sample is labeled with radiolabels or dye moieties such that appropriate detection techniques may localize the position of the bands which are produced by electrophoresis of different length molecules in the gel.
  • Multiplex Sequencing One innovation which attempts to negotiate the limitations associated with gel electrophoresis is multiplex sequencing. 5 This method has been taught by G.M. Church in U.S. Patent Number 4,942,124 and further by G.M. Church and S. Kieffer-Higgins in U.S. Patent Number 5,149,625. These workers have noted that multiple samples may be separated within the same gel region (lane). When these are uniquely labeled with a tag sequence or otherwise uniquely detectable tag, the length-fractionated sequencing reaction products are then serially and uniquely detected according to tag identity. Thus, the pattern resulting from the electrophoretic fractionation of the sequencing products from each sample species is accessed by probing for the respective tag.
  • this method is implemented by transferring or blotting the gel after electrophoresis onto a nitrocellulose or nylon membrane such that the size-separated polynucleotide molecules are deposited onto said membrane with preservation of spatial configuration of the resultant banding pattern.
  • a further step such as UV illumination of said membrane, is performed to further strengthen the immobilization of said polynucleotide molecules.
  • Probing is generally performed with a radiolabelled, dye labeled or enzyme linked oligonucleotide complementary to the respective tag sequence. After image capture of the banding pattern thus revealed, the oligo probe is denatured from its cognate tag sequence and washed away from the membrane.
  • the membrane is then serially reprobed in the same way until many or all distinctly tagged samples have been detected. Data from each probed sample is used to reconstruct sequence information in the same manner as with Maxam and Gilbert or Sanger sequencing methods . Beyond the reduction of electrophoresis time and effort per sample by this method, distinction with unique tags permits several samples to be pooled together, which enables several samples to be processed in only the four reactions specific to each base, significantly reducing handling steps. A drawback of this method has been the difficulty of automating the serial probing of membranes, though efforts have been made in this regard. 6 ' 7 ' 8
  • Sequencing by Hybridization Two general variants of sequencing by hybridization methodology have been proposed.
  • a sample under investigation is hybridized to an array of oligonucleotides situated on a surface 15 , where the composition of an array element is related to the position of said element within said array of oligonucleotides.
  • an array may comprise all possible 10-mer oligos, in which case there are over 10 ⁇ array elements.
  • An unknown sample is denatured and permitted to anneal with said array under stringent conditions. Said array is examined for the presence of bound sample molecules, generally by optical means.
  • the sequence composition of a sufficiently short sample molecule may be reconstructed by using information about which array elements have bound sample molecules and about the compositions of each of these array elements, with algorithms which overlap each of the short sequences (corresponding to the 10-mer oligos in this example) to produce a linear sequence.
  • DNA includes tandem and dispersed repeat elements (including transposons)
  • a particular 10-mer which is one of the more than 10 6 possible 10-mers may occur many times in naturally occurring sequences much shorter than a megabase. 16
  • this method will lead to branch points which ambiguate the sequence data thus obtained.
  • oligo probe libraries or arrays will contain more elements, which thus occur less frequently, but require more surface area and synthesis steps, and will further diminish the ability to discriminate between perfect and mismatched hybridization.
  • hybridization is not perfect for all sequences under any given conditions, as is clear to those familiar with other probe hybridization techniques such as northern blot gel analysis; optimal conditions for a particular probe to form perfect hybrids and not form imperfect or mismatched hybrids vary in a sequence dependent manner, and it is not always simple to predict this optimum even where only a single probe is concerned.
  • optimal conditions for a particular probe to form perfect hybrids and not form imperfect or mismatched hybrids vary in a sequence dependent manner, and it is not always simple to predict this optimum even where only a single probe is concerned.
  • only a subset of elements will display optimal binding discrimination characteristics under any set of particular conditions.
  • sample sequence (which is generally in the form of a phage or plasmid library) is immobilized, generally in the form of bacteriophage plaque or bacterial colony replicas, on a membrane, which is serially probed with a different labeled oligonucleotide of known sequence and length n.
  • the first variant of sequencing by hybridization is, however, proposed as a confirmatory sequencing method to identify any errors in sequence information obtained by other methods, and the same methodology is proposed as a means of classifying polynucleotides in unknown samples, for example, to detect the presence and type of polynucleotides present in clinical isolates.
  • a characteristic pattern which may serve as a highly specific signature may nonetheless be observed.
  • the present invention provides for the parallel detection of polynucleotide species size separated according to multiplex sequencing protocols, which methods are advantageously substituted for previous serial reprobing methods.
  • This parallelism is realized by separately analyzing species handled by multiplex strategies in a length stratified manner. Stratification is accomplished by recovering size fractionated or size separated fractions, and examining these separately. The effort of analyzing many fractions is far offset by the advantages realized by parallel tag detection or probing; while a few hundred fractions may correspond to nested sets of fragments of up to tens or hundreds of bases in length, each fraction yields information about thousands to millions of contiguous sequences.
  • Parallel tag detection is favorably accomplished by hybridization of multiplex sample with one or more stationary arrays of tag specific or sequence-segment specific probes. Information thus obtained is reassembled, according to the presence or absence or a tag, or base- dependent label associated with a tag, in each such fraction and the order of each such fraction in a contiguous series, generally by algorithmic means, to yield linear
  • Separatory coordinate the degree of separation effected between two or more species by some fractionation or separation method.
  • the separatory coordinate of each species is reflected by the distance that species has travelled in the gel matrix after some period of time under the action of an applied field; alternative separatory coordinates are time-of-flight in time-of-flight mas spectroscopic separations, or elution time in membrane-capture capillary gel electrophoresis.
  • the separatory coordinate at which a species is disposed after separation depends, for DNA molecules of length within an appropriate corresponding size range, upon molecular length.
  • separatory coordinate is directly related to separatory mobility, e.g.
  • electrophoretic mobility in electrophoretic separations This term and concept is general, and embraces, for example, elution of molecular species according to the composition of an applied elution buffer gradient applied in HPLC, wherein the composition of the applied elution buffer at the corresponding point along said gradient may be described as the separatory coordinate of molecules which are thence eluted.
  • Stratification the division of a sample or sample population into groups or subpopulations on any basis esp. in order to select a sample from each group or in order to make separate observations on said groups or subpopulations; in the present disclosure, emphasis is placed on division of populations of molecules according to molecular size, length or mass.
  • Tag a region or segment of a molecular species, the composition of which corresponds, preferably uniquely, to the identity of a said species in a population of molecules.
  • Probe a molecule or portion thereof which exhibits binding to a tag, generally with predetermined specificity.
  • Multiplex the processing or conveyance of multiple different entities (e.g. molecules or information,) generally simultaneously, through the same channel.
  • two or more electrical or radiation signals may be combined or mixed onto the same channel or wire, transmitted by this channel or wire, and then "separated" by such means as frequency or amplitude filtering; temporal electronic multiplexing selects one of two or more signals to transmit and applies this one signal to a channel for transmission, while a receiving circuit may demultiplex this signal, if appropriate information is supplied, by switching it to one of two or more output channels.
  • this term initially denoted the performance of reactions on a mixture of several samples, which mixture is then separated in the same separatory channel (e.g.
  • Serial the repetition of the same operations (e.g. transmission, handling, processing or detection) in time on each element of a group comprising multiple different entities (e.g. molecules or information, ) utilizing relatively few (and generally only one) channel, handling, processing or detection means at a time.
  • each probed sequence separated in an individual gel lane is probed one after another in time.
  • the "multiplex" hybridizations or binding reactions performed by these workers actually comprises a plurality of individual hybridization or binding reaction separated in space.
  • these assays demultiplex complex samples in a single parallel step to permit subsequent parallel detection steps.
  • a second example is found in the work of E.S. Yeung and J.A. Taylor (Yeung, E.S.; Taylor, J.A.; 1994.
  • U.S. Patent Number 5,324,401) use the term multiplex to refer to the detection of polynucleotide fragments separated in parallel in an array of capillaries by capillary electrophoresis with parallel detection of signals from each capillary by a CCD camera.
  • the rate limiting step in multiplex sequencing technology is that of serial reprobing of size fractionated polynucleotides species. This rate is on the order of over one hour per membrane, which membrane will generally hold several tens of lanes and which membrane may be usefully reprobed generally fewer than one hundred times. Thus, each reprobing generally yields fewer than one hundred thousand bases of sequence data.
  • Size fractionated sequencing reaction products may be understood as a stratified sample. Rather than the usual method of spatial representation of this stratification within a gel or transferred from a gel to a membrane, complex populations of size fractionated polynucleotides may be stratified by size fractionation with separative isolation, such that each fraction may be independently analyzed.
  • Fraction-wise recovery may be accomplished by dissection of a slab gel into narrow slices (containing one or less band) and electroelution from such slices, dissolution of similarly obtained slice to liberate entrapped polynucleotides, transfer to a membrane with selective and preferably ordered desorption of sample species from said membrane, or other methods of established art.
  • a favorable separation comprises electrophoresis through a slab or capillary gel with collection of fractions exiting the border opposite, in the electric field, that at which the polynucleotide sample was applied to said gel. Liquid fractions thus collected may be directly applied to probe arrays.
  • a particular fraction is examined for the presence or absence of many tags, and optionally the identity of one or more labels which correspond to the identity of the terminal base moiety associated with each tag, in one massively parallel step.
  • a continuous series of adjacent fractions is thus examined with parallel detection such that stratified data regarding a length range of interest are collected (e.g. a few hundred bases of continuous sequence information per unique tag.)
  • Sequence information is reconstructed by ordering the information obtained about tags in each fraction according to the linear order that represents the separation coordinate corresponding to the fractionation method used (e.g.
  • the linear sequence that corresponds to a particular segment of sample polynucleotide material detected by means of a particular and unique tag is represented by the presence or absence of that tag in each size fraction (for "monochrome" or single base moiety specific sequencing reactions,) or by means of detection of the identity of a label associated, by communication within the molecular structure of the sequencing reaction product generally added during said sequencing reaction, with each particular unique tag, which label corresponds in a predetermined way to the identity of the terminal base of a sequencing reaction product (i.e. sample multiplexing both of different polynucleotide segments with associated tags and of sequencing reaction base specificity with associated terminal base specific labeling.)
  • input sample polynucleotides are preferably fragmented to manageable lengths (by standard methods such as shearing, mild digestion with appropriate endonuclease such as DNase I, or restriction enzyme digestion) to convenient length, denatured and permitted to hybridize to a probe array (or other solid, stationary or immobile phase immobilized probe population, such as a column, polymer matrix, etc.,) having a first probe population of identical composition to that to be used in the sequencing protocol. Unbound polynucleotides are collected with a wash step. These unbound nucleotides, by operational definition, do not contain sequences which hybridize to any element in the probe array.
  • the unbound fraction is a polynucleotide sample depleted for fragments bearing sequences which might hybridize with any elements of a given probe population, which might complicate parallel detection or contribute to data loss.
  • a second denaturation step is performed to recover the previously bound fraction.
  • Said previously bound fraction may then be depleted against a second probe population (array or column) of sequence composition designed to be distinct from said first probe population, as was done against said first probe population.
  • This fraction may then, similarly, be analyzed by the methods of the present invention using probe arrays consisting of said second probe population. Such depletion steps may be repeated, against different probe populations, as many times as necessary or desirable to maximize sequence information obtained for a sample.
  • parallel detection of plural species within a fraction may be performed serially on a fraction by fraction basis, or plural fractions may be examined simultaneously by provision of two or more suitable probe arrays.
  • Each probe array may be examined for tag or sample binding by a single, dedicated detection means corresponding to each array, such as a CCD or video microscope, or plural probe arrays may be examined in sequentially by appropriate detection means. Detection rate may then be rate limiting with respect to data collection, but this will in any case be superior to serial reprobing of membranes.
  • a single array may be reused by the use of denaturation and wash steps, which may be verified by examination by the same detection means for residual label or bound polynucleotides.
  • a tag may either be a particular sequence (e.g. of a synthetic oligomer) added to the 5' portion of a primer oligo used in Sanger enzymatic sequencing, which tag composition in some predetermined way corresponds uniquely to the sequence composition or as appropriate to the degenerate sequence composition, of said primer oligo, or may be simply a short but unique sequence of the sample molecules themselves.
  • This latter case poses a two-fold analogy to sequencing by hybridization in that detection occurs according to sample composition and that said detection of sample composition is exploited for parallel classification.
  • the "tag" is merely a portion of the sample itself, i.e. a classification.
  • such a tag is nonetheless probed in an identical manner to tags which are added to a sample, and the tag may be defined merely as that which hybridizes to or associates with a particular probe.
  • Probe populations are here either produced or chosen (including merely by selective observation , detection-recording, or sequence reconstruction of a group of probe specificities within a larger probe population or array) such that only probes that are unlikely to associate with more than one distinct sequence segment of the input sample are used.
  • Probes which associate with more than one such sequence segment will yield data which correspond to the superimposition of the sequence data for all of those sequence segments to which said probes associate, and thus be readily identified, excluded from sequence data reconstruction, and where necessary, noted as information for use in further sample analysis.
  • tagging of a primer may be accomplished through the chemical addition of one or more small molecule haptens or epitopes via linkers such that each class of primer (unique or degenerate) corresponds in a predetermined manner to a unique hapten or unique combination of haptens or epitopes.
  • Detection is here accomplished with affinity arrays, for example, such as those described by S.P.A. Fodor et al. 20
  • the present invention is generally relieved of most of the difficulties accompanying sequencing by hybridization because sequence data reconstruction does not directly depend on the sequence composition of probes or tags .
  • tags are generally produced and/or chosen so as to not have sequence composition identical to any similar length sequence occurring in the sample.
  • a set of tags of this kind and the corresponding probes used may thus be chosen so as to have hybridization specificity properties and discrimination versus heteroduplex binding which are optimal under a single set of conditions or a conveniently small group of conditions.
  • a large array of probes may be produced so as to have optimal specificity under a manageably small number of conditions, i.e. such that parallelism is not compromised by diversity of hybridization stringency optima.
  • Such issues have been discussed by W. Bains 21
  • a fractionation and separation step or steps must provide single base resolution of sequencing reaction product lengths over a usefully long range (generally more than a few tens of bases and preferably more than a few hundred bases. ) Such methods must further be compatible with probing of each such fraction in parallel for the species thus fractionated.
  • Various chromatographic, electrophoretic and spectroscopic methods fulfill these criteria. A few are described, but it will be understood that many different methods are useful for purposes of the present invention and may be employed without departing from the essence of the present invention.
  • Mass spectroscopy 22 ' 23 is attractive because fractionation occurs over a short timescale compared to electrophoretic methods, and size separated products may conveniently be collected. Additionally, field induced or electrophoretic fractionation involving microfabricated 24 structures or devices, or other microstructured materials offers similar attractions of rapid fractionation because of the high degree of structural control, small distances required for transport with high length resolution, and high field strengths realizable. Such devices and materials shall be considered equivalents for purposes of the present invention.
  • Size fractionation is generally a statistical process: transport of a species, i.e. a collection of identical molecules, depends upon many interactions of each molecule of said species with some other material or field. As such, there will be a characteristic mean and a characteristic distribution of mobility or of displacement over time • characteristic of each species. Statistical mechanical processes dictate that each molecule has a very low but not necessarily negligible probability of experiencing transport or displacement of more than a few standard deviations from the mean and most of the distribution. This may be referred to as separatory scatter.
  • Such scatter is one limitation on fractionation resolution; for purposes of the present invention, for a polynucleotide of length m to be within a useful range, there must be good separation between said polynucleotide of length m and those of lengths (m-1) and (m+1) . Any given size fractionation or size separation method must separate species such that a sufficiently large useful range of polynucleotide lengths are obtained. Where a particular species consists of only a few molecules of identical length and sequence, such scatter may compromise detection. Therefore, a fundamental limit to the degree of multiplexing will be imposed- by the fractionation method.
  • a sufficiently large number of identical molecules must be provided to discriminate between erroneously scattered mobilities or displacements and those falling within the bulk of the corresponding distribution, at or near the mean.
  • Relative intensity or detection counts may be used to discriminate between occurrence of such infrequent events and events consistent with average behavior.
  • only a few identical molecules will be necessary for sufficiently refined separation methods. In the case of electrophoretic methods, this may be simply estimated by the intensity ratio of a monodisperse band to the intensity of areas where no bands occur relative to an area of gel where no sample has been applied.
  • Labeling may be accomplished, for example, with affinity labels and affinity association reaction with detection reagents, dye labels, fluorescent labels or radiolabels.
  • detection reagents for example, with affinity labels and affinity association reaction with detection reagents, dye labels, fluorescent labels or radiolabels.
  • detection reagents for example, with affinity labels and affinity association reaction with detection reagents, dye labels, fluorescent labels or radiolabels.
  • detection reagents for example, affinity labels and affinity association reaction with detection reagents, dye labels, fluorescent labels or radiolabels.
  • affinity labeling and optical labeling.
  • affinity labeling of particles such as gold colloids, or of fluorescently derivatized polymer beads. Samples are mixed or exposed to such beads, which are retained only where sufficiently strong and long-lived affinity interaction occur.
  • affinity interactions may be chosen to be highly specific, such that pronounced discrimination of target from non-target molecules is accomplished.
  • Commonly used affinity interactions and labels include: streptavidin and biotin; digoxigenin and anti-digoxigenin antibodies; and, dinitrophenol and anti- dinitrophenol antibodies.
  • a vast number of biological molecules also display such affinity interactions at various degrees of specificity.
  • Nucleotide analogs including analogs capable of terminating the template dependent enzymatic polymerization of polynucleotides, comprising affinity moieties derived from small molecule ligands or haptens have been prepared, are commercially available, and have been used in variations on Sanger enzymatic sequencing methods. Such analogs have been prepared from different nucleotide base moiety composition, including for sets of nucleotide analogs where each base moiety type is in communication with a different affinity ligand.
  • Such analogs may be used with the present invention as follows: a single stranded DNA sample is subjected to Sanger enzymatic sequencing reactions with tagged primers in a single vessel with a set of four such distinctly affinity labeled chain terminator nucleotide analogs and all four of the ordinary deoxyribonucleotides at an appropriate ratio; the reaction products are denatured and subjected to capillary electrophoretic separation with fraction collection (i.e.
  • each aliquot is hybridized to an appropriate probe array specific for tag sequences only; each probe array is exposed to a stoichiometric excess (generally a slurry) of four distinctly fluorescently labeled polymer beads, each of which four types further bears one or more predetermined affinity group of a single type which binds specifically to exactly one of said distinctly affinity labeled chain terminator nucleotide analogs via the affinity label member; the presence, type and optionally also the intensity of fluorescence colocalized with each probe array element is recorded, generally by electronic means such as a color CCD device or video microscope, with data transfer to an electronic computer; computer algorithms are then used to reconstruct data thus obtained from the ensemble of fractions.
  • the color of a bead localized to an array element indicates the identity of the 3' terminal base moiety of polynucleotide molecules of a nucleotide length corresponding to the respective fraction analyzed with said array and comprising the tag sequence probed by said array element.
  • genomic sample is fragmented by physical or enzymatic methods to yield a population of molecules with average fragment size of between about 600 and 1,000 base pairs.
  • a fragmented genomic sample is then depleted of sequences homologous to a first tag-probe array to be used by hybridization under moderately stringent conditions.
  • Non-binding material is collected, and then binding material is collected separately with a denaturing wash, for use in a similar procedure with a second tag-probe array comprising probes of composition different from those of said first tag-probe array.
  • Non- binding material is then cloned by appropriate methods established in the art into a population of plasmid or phagemid vectors wherein each vector comprises a universal priming site immediately upstream of a variable tag sequence which is in turn upstream of a cloning insertion site.
  • the set of said variable tag sequences is that set of sequences complementary to the set of probes of said first tag-probe array, to which said non-binding material did not bind.
  • Such variable tag sequences (and the corresponding respective probe population) are chosen such that no tag sequence is likely to hybridize with any probe complementary to a different tag under moderately stringent conditions; the probe population comprises the set of probes complementary to all of said tag sequences.
  • libraries include those suitable for use with the original multiplex sequencing protocol of Church and Gilbert.
  • the resulting sample is then transformed into a suitable host organism, the population of which is grown and optionally maintained.
  • Template molecules prepared and/or purified in multiplex from such a library are split into four aliquots. Each of these four aliquots is primed by hybridization with a universal primer oligonucleotide derivated with one of four distinct labels. Each of said four aliquots is then subjected to a Sanger elongation reaction in the presence of one of four distinct chain terminating deoxynucleotide triphosphate molecules (e.g.
  • reaction products thus produced comprise a terminal base moiety the identity of which corresponds to the identity of said one of four distinct labels (according to the label derivated primer used with the respective chain terminator in the respective aliquot), with which they are in physical communication. Said four aliquots may then be combined into a single pool.
  • a fluorescently labeled polynucleotide ladder of useful length range and increment (which preferably do not comprise any sequences homologous to any tag sequences used in such a process) may be added to said aliquots, or if they are combined to said pool.
  • Said aliquots or said pool, comprising sequencing product molecules are then size separated by separatory methods and means with single base separatory resolution over some useful size range (e.g.
  • Said fluorescently labeled polynucleotide ladder may facilitate determination of the optimal increment or delay between successive fractions, serving as an internal standard indicative of separation, and may be monitored by appropriate fluorescence detection means (as known within relevant arts;) information thus collected may be used to regulate and control, for example by electronic computer implemented algorithms in combination with a computer controlled fraction collector, the appropriate spacing or timing of collection of separate fractions.
  • oligonucleotide array each element of which comprises a number oligonucleotide probes of substantially identical sequence (probe array) complementary to preferably no more than one variable tag sequence; said oligonucleotide array preferably (though not necessarily) comprises the complete ensemble of oligodeoxyribonucleotide probes complementary to the complete ensemble of tags contained in said genomic library; the composition and identity of each probe as a function of element position in said probe array is preferably known, but at least consistent for all arrays used in one procedure. Stringent washes may then be performed to remove unbound or poorly bound sample molecules.
  • steps developing or amplifying label signal are performed for all fractions or probe arrays (e.g. incubation of sample-hybridized probe arrays with affinity label receptor labeled latex beads, where the spectrum of such fluorescence for a given bead type corresponds distinguishably to the identity of said receptor, and where said receptor uniquely binds one of said four labels where said four labels are affinity labels.)
  • Data regarding the association of label type or bead type with a probe-array element are then collected by optical means such as a CCD camera, and analyzed by computerized image analysis algorithms.
  • sequence data for each clone corresponding to each tag and tag-probe are reconstructed: data obtained from successive probe arrays is sorted so as to arrange label identity data (and hence terminating base identity data) for each probe array element according to probe array element location within said probe array in the order by which successive probe arrays correspond to successive fractions and hence sample molecules differing in length by one base.
  • label identity data and hence terminating base identity data
  • data regarding a particular probe element will consist of information about the identity of labels in association with the corresponding probe element (of identical sequence composition) in each successive probe array, where such data are rearranged to the order corresponding to the order in which successive fractions applied to successive probe arrays were collected.
  • This data is the sequence of the clone corresponding to the tag which is complementary to said particular probe (i.e. that located at (Xj,yk))/ and is of a read length m max - m min +1 •
  • m max - m min +1 •
  • Such a reconstruction process is performed for all probes.
  • the maximum quantity of data which can be obtained is thus (Xmax) (Ymax) (m a ⁇ -m m i n +l) , or 150,000,000 bases using the above parameters.
  • the collected data For example, the collected data:
  • the sequencing reaction products binding to the probe located at coordinates (10,10) comprise the sequence 36-AAGG-39
  • those binding to the probe located at coordinates (10,11) comprise the sequence 36-CGCC-39
  • (11,12) comprise the sequence 36-GATC-39.
  • the length of collected species increases with increasing time (and hence increasing fraction number) so that the sequences of the strands synthesized on input templates by Sanger reactions are 5' -36-AAGG-39, 5' -36-CGCC-39 and 5' -36-GATC-39, respectively.
  • Data thus reconstructed is further examined (for example by computer implemented algorithm) to detect cases where more than one clone has inadvertently bound to the same probe element; the identity of probes binding more than one clone may be noted.
  • the protocol of this example is most rapidly performed with a number of probe arrays equal to the number of separate length fractions collected and a similar number of label detection means.
  • the above example protocol comprises the steps: 1. Fragment a genomic sample; 2. Deplete said sample against the probe array which will be used to detect and discriminate tags; 3. Cloning into a population of vectors each comprising a universal priming site, a variable tag sequence and a cloning site; 4. Transform into a suitable host organism, grow as a library and. purify template in multiplex;
  • Genomic DNA may be digested with a particular restriction enzyme, optionally dephosphorylated, and ligated to a linker bearing an affinity or optical label, depleted against probe arrays, and subjected to appropriate sequencing reactions (e.g. either Maxam and Gilbert chemical sequencing methods, or subjected to partial exonuclease digestion followed by Sanger enzymatic sequencing methods.)
  • probing corresponds to hybridization to a small segment of the input genomic sequence on each fragment, where probes are selected or produced such that each restriction fragment is most likely to be probed by zero or one probe array element (i.e. one probe. )
  • Such reactions are then separated and detected in multiplex and parallel, according to the general methods of the present invention. While this simple method is not likely to yield complete sequence information about a genome, it may yield a very large quantity of sequence information in a comparatively quite small number of steps. Thus it may be regarded as a broad spectrum data collection method.
  • multiplex separation methods apply to other macromolecular samples, such as restriction digestion products of DNA samples.
  • Multiplex detection i.e. parallel detection on a fraction by fraction basis, is similarly applicable in accordance with the present invention.
  • probing may detect a sequence occurring within a restriction fragment, and the fraction in which a probed sequence or (categorical) tag occurs indicates the length of the fragment thus identified.
  • Such a method may be used to rapidly profile a large DNA sample, and may further be employed to obtain data useful in the disambiguation of sequence data comprising branch points (divergences and convergences) which occur in sequencing methods which reassemble linear sequence information from information about shorter fragments, such as sequencing by hybridization.
  • branch points arise, for example, in sequencing by hybridization, where a given n-mer occurs more than once in a given sample.
  • Internal tags comprising sequences found in stretches of sequence data near branch points are examined to detect length ranges between sites for the restriction enzyme used. When a tag sequence matches a sequence near an ambiguous branch, the distance in bases from said branch point to the restriction sites corresponding to the enzyme used are determined to obtain a possible length.
  • a branching may be selected as the correct sequence; alternatively, restriction analysis data obtained above may be used to eliminate a subset of branchings which are inconsistent with this restriction data.
  • restriction digested samples may be fractionated into only a few fractions, possibly as few as only two fractions (e.g. one fraction containing all fragments 1 kilobase or shorter and another fraction containing all fragments longer than one kilobase, ) which are then probed as above, e.g. for internal tags.
  • fractions e.g. one fraction containing all fragments 1 kilobase or shorter and another fraction containing all fragments longer than one kilobase, ) which are then probed as above, e.g. for internal tags.
  • data obtained will classify each probed sequence into one of two classes or categories.
  • F n different sample profiles may be obtained from (F)(n) probes, without quantitating binding to each probe. If binding to probes is quantitated with Q levels distinguishable (which is possible with sufficiently sensitive detectors with sufficient dynamic range) this number of profiles is multiplied by a further factor of Q n .
  • Q levels distinguishable (which is possible with sufficiently sensitive detectors with sufficient dynamic range) this number of profiles is multiplied by a further factor of Q n .
  • the minimal case of two fractions can yield 2 n different detectable profiles without quantitation; for large n, this can be enormous discriminatory power which, because of the use of fractionation, is applicable to detecting length polymorphisms.
  • An automated device performing the method which is the essence of the present invention comprises a separatory channel, fraction collection means, probe binding means and detection means. Where fractions are not collected by direct transfer from said separatory channel to said probe binding means, fraction transfer means must also be provided. Where samples are to be labeled according to procedures requiring multiple steps (e.g. affinity moiety labeling of samples followed in a later step by the binding of beads or particles comprising anti-ligands, receptors or other specific affinity groups which specifically recognize said affinity moiety, ) means performing any subsequent of said multiple steps must likewise be provided.
  • this may comprise a first reservoir holding a slurry of affinity labeled beads or mixtures thereof, a pump, and an outflow which may be positioned to deposit a controlled quantity of affinity labeled beads onto the surface of said array, a second reservoir and a second pump for wash solutions to eliminate unbound beads from the surface of said arrays, and a third reservoir to collect waste solutions.
  • Said first reservoir which may contain a slurry, preferably is in communication with agitation means to prevent settling of particulates, or comprises integrated agitation means.
  • Detection means will correspond in type to the label (e.g.
  • fluorescent dye moiety fluorescent bead, colloid,
  • means which scan or otherwise move said detection means relative to said probe binding means such that one detection means may examine many of the probe binding means for sample binding, for example such that one CCD may examine all probes used with particular fraction and further thus examine multiple fractions. All such means may be contained or enclosed within a single cabinet or case. While such an apparatus would simplify manual performance of the method of the present invention, it is preferred that such a device further comprise a computer system for controlling separation, sample fraction collection, sample fraction transfer, probe binding, detection, detector scanning relative to probe binding means, and to record collected data electronically. The same computer system or a different computer system may be employed to perform algorithms on collected data to reconstruct sequence data and align said sequence data.
  • a specific example comprises the following: one or more capillaries each comprising a sample input port and an outlet and filled with gel or low viscosity matrix separatory media, an electrical power supply to provide the electric field for electrophoresis, a plurality of oligonucleotide probe arrays situated on an electronically controlled positioner (analogous to a fraction collector) which may translates each of said oligonucleotide probe arrays into position juxtaposed to the outlet of said capillary and may also translate said oligonucleotide probe arrays into position with provided means performing said subsequent labeling steps and into position for detection by a provided detection means, such as a color CCD camera; data collected by said CCD camera are transferred through a communications channel to a computer controller system provided to automate the device of the present example, and are stored with and/or without further algorithmic processing.
  • Said oligonucleotide probe arrays preferably comprise on their surface, preferably integrated at one or more borders of said array, an electrode which serves to provide one pole of the electrophoretic field.
  • fractions may be electrophoresed (more specifically, electroeluted) directly onto the target array, and the field thus established may sweep sample molecules across the surface of said array concurrent to fraction collection.
  • Such a device preferably also contains one or more temperature control element for controlling binding reactions, e.g. hybridization stringency or dissociation temperature.
  • Said oligonucleotide arrays are preferably translated such that they are contacted with said temperature control elements as sample fractions are applied or thereafter.
  • detection means may be selected from a CCD camera, a cooled CCD camera, a photon counting CCD camera, a video microscope, a video confocal microscope, a scanning laser confocal microscope, though one of ordinary skill in the art will recognize that other detection means exist.
  • cooling a CCD camera improves signal-to-noise ' characteristics and thus permits either more rapid or more sensitive detection of optical labels.
  • an appropriate light source must also be provided.
  • a laser or laser diode of appropriate wavelength may serve this function.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Détection parallèle d'espèces de polynucléotides séparées par tailles selon des protocoles de séquençage multiplexe qui remplacent avantageusement des procédés de resondage en série antérieurs. Ce parallélisme est réalisé par analyse séparée d'espèces manipulées à l'aide de stratégies multiplex d'une manière stratifiée en longueur. On effectue la stratification en récupérant des fractions fractionnées par taille ou séparées par taille et en les examinant séparément. Les contraintes de l'analyse de nombreuses fractions sont compensées de loin par les avantages qu'entraîne la détection ou le sondage parallèle par marqueur. Si à peine quelques centaines de fractions peuvent correspondre à des séries imbriquées de fragments comportant jusqu'à des dizaines ou des centaines de bases en longueur, chaque fraction donne des informations sur des milliers à des millions de séquences contiguës. La détection parallèle par marqueur s'effectue favorablement par hybridation d'un échantillon multiplex avec un ou plusieurs ensembles stationnaires de sondes spécifiques de marqueurs ou spécifiques de segments de séquences. Les informations ainsi obtenues sont rassemblées, selon la présence ou l'absence de marqueur ou d'indicateur dépendant d'une base associé à un marqueur, dans chaque fraction de ce type, et selon l'ordre de ces fractions dans une série contiguë, généralement par des moyens algorithmiques, pour produire des informations de séquence linéaire.
PCT/US1996/007202 1995-05-19 1996-05-16 Sequençage de polynucleotides parallele et en multiplex WO1996036737A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU57976/96A AU5797696A (en) 1995-05-19 1996-05-16 Parallel multiplex polynucleotide sequencing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44509495A 1995-05-19 1995-05-19
US08/445,094 1995-05-19

Publications (1)

Publication Number Publication Date
WO1996036737A1 true WO1996036737A1 (fr) 1996-11-21

Family

ID=23767586

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/007202 WO1996036737A1 (fr) 1995-05-19 1996-05-16 Sequençage de polynucleotides parallele et en multiplex

Country Status (2)

Country Link
AU (1) AU5797696A (fr)
WO (1) WO1996036737A1 (fr)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998015644A2 (fr) * 1996-09-27 1998-04-16 The Chinese University Of Hong Kong Procede de sequencage en parallele de polynucleotides
WO1998044152A1 (fr) * 1997-04-01 1998-10-08 Glaxo Group Limited Methode de sequençage d'acide nucleique
WO1999057308A1 (fr) * 1998-05-06 1999-11-11 Genprofile Ag Methode pour l'identification et la representation de differences interindividuelles de sequences d'adn
WO2000032824A2 (fr) * 1998-12-03 2000-06-08 Pe Corporation (Ny) Evaluation de la longueur de sequences nucleotidiques repetitives par extension discontinue d'amorce
US6124092A (en) * 1996-10-04 2000-09-26 The Perkin-Elmer Corporation Multiplex polynucleotide capture methods and compositions
WO2000056921A2 (fr) * 1999-03-22 2000-09-28 Paul Cullen Combinaison d'acide nucleique
US6235483B1 (en) 2000-01-31 2001-05-22 Agilent Technologies, Inc. Methods and kits for indirect labeling of nucleic acids
DE10113711A1 (de) * 2001-03-16 2002-09-26 Lifebits Ag Verfahren zum Nachweis biochemischer Reaktionen und Messträger zur Durchführung des Verfahrens
US6480791B1 (en) 1998-10-28 2002-11-12 Michael P. Strathmann Parallel methods for genomic analysis
EP2327797A1 (fr) * 1997-04-01 2011-06-01 Illumina Cambridge Limited Methode de séquençage d'acides nucléiques
US7972820B2 (en) 2000-12-08 2011-07-05 Illumina Cambridge Limited Isothermal amplification of nucleic acids on a solid support
US8140148B2 (en) 1998-01-20 2012-03-20 Boston Scientific Scimed Ltd. Readable probe array for in vivo use
US8182994B2 (en) 2009-09-15 2012-05-22 Illumina Cambridge Limited Centroid markers for image analysis of high denisty clusters in complex polynucleotide sequencing
US8728764B2 (en) 2008-10-02 2014-05-20 Illumina Cambridge Limited Nucleic acid sample enrichment for sequencing applications
US9096898B2 (en) 1998-05-01 2015-08-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9101933B2 (en) 2008-10-10 2015-08-11 University Of Hull Microfluidic apparatus and method for DNA extraction, amplification and analysis
US9243284B2 (en) 2000-12-01 2016-01-26 Life Technologies Corporation Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis
US9512478B2 (en) 2007-02-02 2016-12-06 Illumina Cambridge Limited Methods for indexing samples and sequencing multiple polynucleotide templates

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942124A (en) * 1987-08-11 1990-07-17 President And Fellows Of Harvard College Multiplex sequencing
US5237016A (en) * 1989-01-05 1993-08-17 Siska Diagnostics, Inc. End-attachment of oligonucleotides to polyacrylamide solid supports for capture and detection of nucleic acids
US5409811A (en) * 1988-07-12 1995-04-25 President And Fellows Of Harvard College DNA sequencing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942124A (en) * 1987-08-11 1990-07-17 President And Fellows Of Harvard College Multiplex sequencing
US5409811A (en) * 1988-07-12 1995-04-25 President And Fellows Of Harvard College DNA sequencing
US5237016A (en) * 1989-01-05 1993-08-17 Siska Diagnostics, Inc. End-attachment of oligonucleotides to polyacrylamide solid supports for capture and detection of nucleic acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. MOL. BIOL., 1975, Vol. 94, SANGER et al., "A Rapid Method for Determining Sequences in DNA by Primed Synthesis with DNA Polymerases", pages 441-448. *

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998015644A3 (fr) * 1996-09-27 1998-05-22 Univ Hong Kong Chinese Procede de sequencage en parallele de polynucleotides
US7083929B2 (en) 1996-09-27 2006-08-01 The Chinese University Of Hong Kong Parallel polynucleotide sequencing method
US5935793A (en) * 1996-09-27 1999-08-10 The Chinese University Of Hong Kong Parallel polynucleotide sequencing method using tagged primers
WO1998015644A2 (fr) * 1996-09-27 1998-04-16 The Chinese University Of Hong Kong Procede de sequencage en parallele de polynucleotides
US6124092A (en) * 1996-10-04 2000-09-26 The Perkin-Elmer Corporation Multiplex polynucleotide capture methods and compositions
US6514699B1 (en) 1996-10-04 2003-02-04 Pe Corporation (Ny) Multiplex polynucleotide capture methods and compositions
US9593328B2 (en) 1997-04-01 2017-03-14 Illumina, Inc. Method of nucleic acid amplification
EP2327797A1 (fr) * 1997-04-01 2011-06-01 Illumina Cambridge Limited Methode de séquençage d'acides nucléiques
EP3034626A1 (fr) * 1997-04-01 2016-06-22 Illumina Cambridge Limited Methode de séquencage d'acide nucléique
US8993271B2 (en) 1997-04-01 2015-03-31 Illumina, Inc. Method of nucleic acid amplification
EP1498494A3 (fr) * 1997-04-01 2007-06-20 Solexa Ltd. Procédé de séquencage d'acides nucléiques
US8476044B2 (en) 1997-04-01 2013-07-02 Illumina, Inc. Method of nucleic acid amplification
US8143008B2 (en) 1997-04-01 2012-03-27 Illumina, Inc. Method of nucleic acid amplification
WO1998044152A1 (fr) * 1997-04-01 1998-10-08 Glaxo Group Limited Methode de sequençage d'acide nucleique
US7985565B2 (en) 1997-04-01 2011-07-26 Illumina, Inc. Method of nucleic acid amplification
US9902951B2 (en) 1997-04-01 2018-02-27 Illumina, Inc. Method of nucleic acid amplification
US6773887B2 (en) 1997-05-27 2004-08-10 Applera Corporation Length determination of nucleic acid repeat sequences by discontinuous primer extension
US6309829B1 (en) 1997-05-27 2001-10-30 Pe Corporation (Ny) Length determination of nucleic acid repeat sequences by discontinuous primer extension
US7294464B2 (en) 1997-05-27 2007-11-13 Applera Corporation Length determination of nucleic acid repeat sequences by discontinuous primer extension
US7414115B2 (en) 1997-05-27 2008-08-19 Applied Biosystems Inc. Length determination of nucleic acid repeat sequences by discontinuous primer extension
US8140148B2 (en) 1998-01-20 2012-03-20 Boston Scientific Scimed Ltd. Readable probe array for in vivo use
US9540689B2 (en) 1998-05-01 2017-01-10 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9458500B2 (en) 1998-05-01 2016-10-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9957561B2 (en) 1998-05-01 2018-05-01 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9725764B2 (en) 1998-05-01 2017-08-08 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US10208341B2 (en) 1998-05-01 2019-02-19 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9212393B2 (en) 1998-05-01 2015-12-15 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US10214774B2 (en) 1998-05-01 2019-02-26 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US9096898B2 (en) 1998-05-01 2015-08-04 Life Technologies Corporation Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
WO1999057308A1 (fr) * 1998-05-06 1999-11-11 Genprofile Ag Methode pour l'identification et la representation de differences interindividuelles de sequences d'adn
US6480791B1 (en) 1998-10-28 2002-11-12 Michael P. Strathmann Parallel methods for genomic analysis
JP2002531106A (ja) * 1998-12-03 2002-09-24 ピーイー コーポレイション （エヌワイ） 不連続プライマ−伸長による核酸反復配列の長さ決定
WO2000032824A3 (fr) * 1998-12-03 2001-05-10 Perkin Elmer Corp Evaluation de la longueur de sequences nucleotidiques repetitives par extension discontinue d'amorce
WO2000032824A2 (fr) * 1998-12-03 2000-06-08 Pe Corporation (Ny) Evaluation de la longueur de sequences nucleotidiques repetitives par extension discontinue d'amorce
WO2000056921A2 (fr) * 1999-03-22 2000-09-28 Paul Cullen Combinaison d'acide nucleique
WO2000056921A3 (fr) * 1999-03-22 2002-03-14 Paul Cullen Combinaison d'acide nucleique
US6235483B1 (en) 2000-01-31 2001-05-22 Agilent Technologies, Inc. Methods and kits for indirect labeling of nucleic acids
US9845500B2 (en) 2000-12-01 2017-12-19 Life Technologies Corporation Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis
US9243284B2 (en) 2000-12-01 2016-01-26 Life Technologies Corporation Enzymatic nucleic acid synthesis: compositions and methods for inhibiting pyrophosphorolysis
US7972820B2 (en) 2000-12-08 2011-07-05 Illumina Cambridge Limited Isothermal amplification of nucleic acids on a solid support
DE10113711A1 (de) * 2001-03-16 2002-09-26 Lifebits Ag Verfahren zum Nachweis biochemischer Reaktionen und Messträger zur Durchführung des Verfahrens
US9512478B2 (en) 2007-02-02 2016-12-06 Illumina Cambridge Limited Methods for indexing samples and sequencing multiple polynucleotide templates
US10988806B2 (en) 2007-02-02 2021-04-27 Illumina Cambridge Limited Methods for indexing samples and sequencing multiple polynucleotide templates
US10457985B2 (en) 2007-02-02 2019-10-29 Illumina Cambridge Limited Methods for indexing samples and sequencing multiple polynucleotide templates
US11634768B2 (en) 2007-02-02 2023-04-25 Illumina Cambridge Limited Methods for indexing samples and sequencing multiple polynucleotide templates
US8728764B2 (en) 2008-10-02 2014-05-20 Illumina Cambridge Limited Nucleic acid sample enrichment for sequencing applications
US9702002B2 (en) 2008-10-02 2017-07-11 Illumina, Inc. Nucleic acid sample enrichment for sequencing applications
US11866780B2 (en) 2008-10-02 2024-01-09 Illumina Cambridge Limited Nucleic acid sample enrichment for sequencing applications
US9101933B2 (en) 2008-10-10 2015-08-11 University Of Hull Microfluidic apparatus and method for DNA extraction, amplification and analysis
US9758825B2 (en) 2009-09-15 2017-09-12 Illumina Cambridge Limited Centroid markers for image analysis of high density clusters in complex polynucleotide sequencing
US8795971B2 (en) 2009-09-15 2014-08-05 Illumina Cambridge Limited Centroid markers for image analysis of high density clusters in complex polynucleotide sequencing
US8541172B2 (en) 2009-09-15 2013-09-24 Illumina Cambridge Limited Method for sequencing a polynucelotide template
US8182994B2 (en) 2009-09-15 2012-05-22 Illumina Cambridge Limited Centroid markers for image analysis of high denisty clusters in complex polynucleotide sequencing

Also Published As

Publication number Publication date
AU5797696A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
WO1996036737A1 (fr) Sequençage de polynucleotides parallele et en multiplex
EP0989193B1 (fr) Procédé d'analyse d'ADN
JP4608171B2 (ja) 質量ラベル
EP1586068B1 (fr) Methodes d'analyse de populations de polymeres
US6048691A (en) Method and system for performing a binding assay
US7604941B2 (en) Nucleotide sequencing via repetitive single molecule hybridization
Guetens et al. Nanotechnology in bio/clinical analysis
JP2008532003A5 (fr)
EP3411496A1 (fr) Identification moléculaire avec une précision de localisation sous-nanométrique
US6312904B1 (en) Characterizing nucleic acid
US5817464A (en) Fractionation method for nucleotide fragments
CN115109842A (zh) 用于准确的平行定量核酸的高灵敏度方法
US9416401B2 (en) Method for determining amounts of polynucleotide sequences present in cell or tissue samples
Lipshutz et al. Advanced DNA sequencing technologies
US20060110764A1 (en) Large-scale parallelized DNA sequencing
JP2005528909A (ja) コンビナトリアルオリゴヌクレオチドｐｃｒの改善方法
Smith Separation and analysis of DNA by electrophoresis
CN117625763A (zh) 准确地平行定量变体核酸的高灵敏度方法
Sequencing Advanced Detectors for Mass Spectrometry
Hood et al. DNA Sample Manipulation and
Omori et al. Comparative PCR: A simple and sensitive method for quantifying low-abundance mRNA species
JP2001095570A (ja) 核酸検出法
JP2001103999A (ja) 核酸検出法

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TT UA UG UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA